Vijay Aggarwal has joined the board of directors of IBT Reference Laboratory, the international contract research and diagnostic testing lab said this week.
Aggarwal will provide IBT with strategic counsel in the areas of new business initiatives, operational protocol, and research and development. He currently serves as president and chief executive officer of Aureon Laboratories. Prior to joining Aureon, Aggarwal held positions at AAI Development Services, SmithKline Beecham Clinical Laboratories, and Quest Diagnostic Ventures.
He holds a PhD in pharmacology and toxicology from the Medical College of Virginia.